Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04210986 · ClinicalTrials.gov registry record · Phase 1
Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial
A Phase 1 study, sponsored by Steadman Philippon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT04210986 is a Phase 1 study that has completed, run by Steadman Philippon Research Institute. The registered enrollment target is 75 participants.
The verdict
NCT04210986, a Phase 1 study, has completed, sponsored by Steadman Philippon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis
Interventions
- DRUG Placebo oral capsule
- DIETARY_SUPPLEMENT Fisetin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2023-02-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04210986
The ClinicalTrials.gov registry entry for NCT04210986 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steadman Philippon Research Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT04210986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04210986 about?
NCT04210986 is a clinical study titled "Senolytic Drugs Attenuate Osteoarthritis-Related Articular Cartilage Degeneration: A Clinical Trial". Phase I/II randomized, double-blind, placebo-controlled clinical trial to test the safety and efficacy of Fisetin for treating mild to moderate osteoarthritis
What is the current status of trial NCT04210986?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2020-01-06. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT04210986?
The interventions under investigation include: Placebo oral capsule (DRUG), Fisetin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04210986?
This trial is sponsored by Steadman Philippon Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.